Evidence map›Paper›PMID 38021092›Full record

ArticleClinical and translational radiation oncology2024

Non-invasive physical plasma for preventing radiation dermatitis in breast cancer: Results from an intrapatient-randomised double-blind placebo-controlled trial.

Cas Stefaan Dejonckheere, Julian Philipp Layer, Younèss Nour, Katharina Layer, Andrea Glasmacher, Shari Wiegreffe, Arne Fuhrmann, Lara Caglayan, Franziska Grau, Gustavo Renato Sarria and 19 more

Open access · goldAbstract read
In one paragraph

Article in Clinical and translational radiation oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Identification of the skin microbiome as an emerging and modifiable risk factor for radiation dermatitis in breast cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 3 institutions in 3 countries.

Cas Stefaan DejonckheereDepartment of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Julian Philipp LayerDepartment of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Younèss NourDepartment of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Katharina LayerDepartment of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Andrea GlasmacherDepartment of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Shari WiegreffeDepartment of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Arne FuhrmannDepartment of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Lara CaglayanDepartment of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Franziska GrauDepartment of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Gustavo Renato SarriaDepartment of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Davide ScafaDepartment of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany.
David KochDepartment of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Martina HeimannDepartment of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Christina LeitzenDepartment of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Mümtaz Ali KöksalDepartment of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Fred RöhnerDepartment of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Thomas MüdderDepartment of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Egon DejonckheereFaculty of Psychology and Educational Sciences, KU Leuven, 3000 Leuven, Belgium.
Frederic Carsten SchmeelDepartment of Neuroradiology, University Hospital Bonn, 53127 Bonn, Germany.
Teresa AnzböckDepartment of Gynaecology, Division of Gynaecological Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Kira LindnerDepartment of Gynaecology, Division of Senology, University Hospital Bonn, 53127 Bonn, Germany.
Anne BachmannDepartment of Gynaecology, Division of Senology, University Hospital Bonn, 53127 Bonn, Germany.
Alina AbramianDepartment of Gynaecology, Division of Senology, University Hospital Bonn, 53127 Bonn, Germany.
Christina KaiserDepartment of Gynaecology, Division of Senology, University Hospital Bonn, 53127 Bonn, Germany.
Andree FaridiDepartment of Gynaecology, Division of Senology, University Hospital Bonn, 53127 Bonn, Germany.
Alexander MusteaDepartment of Gynaecology, Division of Gynaecological Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Frank Anton GiordanoDepartment of Radiation Oncology, University Medical Center Mannheim, 68167 Mannheim, Germany.
Matthias Bernhard StopeDepartment of Gynaecology, Division of Gynaecological Oncology, University Hospital Bonn, 53127 Bonn, Germany.
Leonard Christopher SchmeelDepartment of Radiation Oncology, University Hospital Bonn, 53127 Bonn, Germany.
University Hospital Bonn · DEHeidelberg University · DETilburg University · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Purpose: To investigate the effect of topical non-invasive physical plasma (NIPP), a volatile mix generated out of ambient air, on prevention of acute radiation dermatitis (RD) during and after whole-breast irradiation (WBI). Materials and Methods: Lateral and medial breast halves were randomised within each patient to receive either 120 s of NIPP or sham treatment daily during WBI. Standard skin care with urea lotion was applied to the whole breast. Blinded acute skin toxicity was assessed weekly for each breast half separately and included clinician- (CTCAE) and patient-reported (modified RISRAS), and objective (spectrophotometry) assessments. As an additional external control, a comparable standard of care (SoC) patient collective from a previous prospective trial was used. Results: Sixty-four patients were included. There were no significant differences between breast halves. Post-hoc comparison with a similar SoC control collective revealed OR = 0.28 (95% CI 0.11-0.76; Conclusion: Even though there were no differences between intrapatient-randomised breast halves, the overall incidence and severity of acute radiation-induced skin toxicity were considerably lower when compared to a prospectively collected SoC cohort. Our data suggest the potential benefit of NIPP in RD prevention. A randomised trial with a physical control group is warranted to confirm these promising results (DRKS00026225).

Indexed as

Breast cancerCold atmospheric plasmaNon-invasive physical plasmaRadiation dermatitisRadiation therapyRandomised controlled trial

Identifiers

PMID38021092
PMCPMC10654149
OpenAlexW4388331437

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.